tapentadol tartrate

Poland

Drugs containing this active substance

  • TADOMON

    The medicine is used in the treatment of severe, chronic pain in adults and in children and adolescents over 6 years of age, which cannot be controlled by other analgesic (opioid) medicines.

    Form: tablets, prolonged release

    Active substance Dosage
    tapentadol tartrate 41.9525 mg

    ATC: N02AX06

    Manufacturer: G.L. Pharma GmbH Laboratorios Liconsa S.A.

  • TADOMON

    The medicine is used to treat severe, chronic pain in adults and in children and adolescents over 6 years of age, which cannot be controlled with other opioid analgesics.

    Form: tablets, prolonged release

    Active substance Dosage
    tapentadol tartrate 83.905 mg

    ATC: N02AX06

    Manufacturer: G.L. Pharma GmbH Laboratorios Liconsa S.A.

  • TADOMON

    The medicine is used to treat severe, chronic pain in adults and in children and adolescents over 6 years of age, which cannot be managed with other opioid analgesics.

    Form: tablets, prolonged release

    Active substance Dosage
    tapentadol tartrate 167.81 mg

    ATC: N02AX06

    Manufacturer: G.L. Pharma GmbH Laboratorios Liconsa S.A.

  • TADOMON

    The medicine is used to treat severe, chronic pain in adults and in children and adolescents over 6 years of age, which cannot be managed with other analgesic (opioid) medicines.

    Form: tablets, prolonged release

    Active substance Dosage
    tapentadol tartrate 251.715 mg

    ATC: N02AX06

    Manufacturer: G.L. Pharma GmbH Laboratorios Liconsa S.A.

  • TADOMON

    The medicine is used to treat severe, chronic pain in adults and in children and adolescents over 6 years of age, which cannot be controlled with other painkillers (opioids).

    Form: tablets, prolonged release

    Active substance Dosage
    tapentadol tartrate 335.62 mg

    ATC: N02AX06

    Manufacturer: G.L. Pharma GmbH Laboratorios Liconsa S.A.

  • TADOMON

    The medicine is used to treat severe, chronic pain in adults and in children and adolescents over 6 years of age, which cannot be managed with other painkillers (opioids).

    Form: tablets, prolonged release

    Active substance Dosage
    tapentadol tartrate 419.525 mg

    ATC: N02AX06

    Manufacturer: G.L. Pharma GmbH Laboratorios Liconsa S.A.